Analgesics
Antiandrogens
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lactoferrin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Peg.. Lambda
Quercetin
Remdesivir
Vitamins

Other
Feedback
Home
Top
Results
Abstract
All quercetin studies
Meta analysis
 
Feedback
Home
c19early.org COVID-19 treatment researchQuercetinQuercetin (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 96% Improvement Relative Risk Symp. case 98% Quercetin  Turobkulovich et al.  Prophylaxis Is prophylaxis with quercetin beneficial for COVID-19? Prospective study of 90 patients in Uzbekistan Lower mortality (p<0.0001) and fewer symptomatic cases (p<0.0001) c19early.org Turobkulovich et al., Emergent: J. Edu.., Jan 2023 Favors quercetin Favors control

Applications of quercetin for the prevention of COVID-19 in healthcare workers

Turobkulovich et al., Emergent: Journal of Educational Discoveries and Lifelong Learning
Jan 2023  
  Twitter
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Prospective study of healthcare workers in Uzbekistan showing lower mortality and cases with quercetin prophylaxis. Very minimal details are provided, there is no baseline information, and control mortality is very high. This study is excluded in meta analysis: minimal information, no baseline details, very high control mortality without explanation.
This study includes vitamin C and quercetin.
risk of death, 96.4% lower, RR 0.04, p < 0.001, treatment 0 of 70 (0.0%), control 6 of 20 (30.0%), NNT 3.3, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm).
risk of symptomatic case, 98.5% lower, RR 0.02, p < 0.001, treatment 1 of 70 (1.4%), control 19 of 20 (95.0%), NNT 1.1.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Turobkulovich et al., 25 Jan 2023, prospective, Uzbekistan, peer-reviewed, 2 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperQuercetinAll
APPLICATIONS OF QUERCETIN FOR THE PREVENTION OF COVID-19 IN HEALTHCARE WORKERS Babanazarov Umid Turobkulovich, Sharopov Umarxo`ja Ravshanovich Bukhara State Medical Institute
The topic of coronavirus infection is becoming more and more relevant, especially during the pandemic of this infection. Also, it is important to study the effects of known drugs on the infectivity and course of SARS-CoV-2 infection. This article reveals significant positive results when using the drug quertin and its combination with ascorbic acid on the morbidity rate of medical workers working with COVID-19 patients.
References
Babanazarov Umid Turobkulovich, Kayimov, Tuymurodovich, Coronavirus Infection -A Trigger Factor in Liver Damage, Eurasian Research Bulletin
Oblokulov, Musaeva, Elmurodova, Clinical and epidemiological characteristics of a new coronavirus infection (COVID-19) // New day in medicine
Salieva, Azizov, Dadakhonova, Musayeva, On improving health care// Achievements of science and education
Samadov, Musayeva, The trend of the development of the epidemic process of hepatitis C in Uzbekistan // Materials of the IV International Scientific and Practical Conference "Liki -lyudini. Suchasni problems pharmacotherapy i priznachennya likarskikh zasobiv
Sh, Saitov Sh, Nabieva, Nutritional requirements and the use of biologically active additives in COVID-19 // New Day in medicine
Бабаназаров, Уроков, Бахронов, Заболевания, None, ПЕЧЕНИ ВО ВРЕМЯ ПАНДЕМИИ COVID-19
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit